Customize Your Learning Experience!

Mix-and-match sessions from these additional co-located conferences at no additional cost:

• Antibody Development & Production
• Analytical Technologies for Biotherapeutic Development
• Biobetters & Biosimilars: Technologies & Development Strategies

Arrive early so you can attend the first half of the week, Feb. 27-28 for these conferences:

• Process & Product Validation
• Technology Transfer for Biopharmaceuticals
• Outsourcing Manufacturing of Biopharmaceuticals
• Biopharmaceutical Raw Materials throughout the Product Lifecycle
• Viral Safety for Biologicals

Get the Most Out of Your Budget with the "All Access Pass" to Attend Sessions from All 9 Conferences

View the Agenda-At-A-Glance for the Entire Week.

Special Discounted Hotel Rate

Special Discounted Hotel Rate Available Until February 3, 2012.
To book your room, call 1-800-HILTONS and mention that you are an IBC attendee at this event.

Request Your 2012 Event Updates

Join the priority contact list today!

See Who Attended in 2011

Read a sample of who attended the conference in 2011.
Updated: March 16, 2011

The Recombinant Protein & Complex Biologic Development & Production conference covers the entire spectrum of topics related to improving the efficiency of developing and producing next generation and novel molecules. Companies are now looking "beyond antibodies" to new formats for making better drugs which has dramatically expanded the scope of novel molecules. This event is designed to bring together industry experts representing companies of all sizes to share successful approaches that can help you overcome the unique technical and scientific challenges in upstream and downstream processing.

This Conference Will Help You:

• Expanded coverage of the critical achievements to overcome the challenges of development, scale up and characterization of novel molecules
• Gain insights from companies implementing disruptive technologies and innovative process solutions to improve speed and cost of development

The Agenda Covers these Critical Topics:

• Successful and alternative approaches to scaling up complex biologics
• Improve speed and reduce cost of upstream and downstream process development
• Explore the disruptive technologies that are causing paradigm shifts in upstream and downstream processing
• Leveraging innovation for more efficient development and manufacturing of protein drugs and biobetters
• Effective development of novel proteins with increased half-life and bioavailability
• Approaches to increase molecular understanding and the impact on industrial production
• Developing novel proteins that fit into a platform-based downstream purification process
• Compare the latest analytical

Find Out How the Industry is Addressing these Critical Topics

Comparability Within A Single Product Differs from Biosimilarity Between Two Products
Anthony S. Lubiniecki, Sc.D.
Johnson & Johnson Pharmaceutical R&D, Inc.

Path to Approval for Antibody Drug Conjugates
Morris Rosenberg, D.Sc.
Seattle Genetics

The Challenge of Discovery and Developing Biobetters - They Had Better Be Better!
Bill Strohl, Ph.D.
Centocor R&D

Cell-Free Production of Complex Proteins and Protein Complexes
James R. Swartz, D.Sc., M.S.
Stanford University

Leveraging Innovation for More Efficient Development and Manufacturing of Protein Drugs and Biobetters
Jens H. Vogel, Ph.D.
Bayer Healthcare

Special thanks to the Scientific Advisory Committee for their help in developing this program.
» View the list of committee members